Literature DB >> 29773027

Functions of CD40 and Its Ligand, gp39 (CD40L).

Jon D Laman1, Eric Claassen1, Randolph J Noelle2.   

Abstract

Initially, a role for the interaction between CD40, expressed on B cells, and gp39 (CD40L), expressed on activated T cells, has been defined in humoral immunity. CD40-CD40L interaction is an essential signal for B cell proliferation, expression of activation markers, immunoglobulin production, and isotype switching. CD40-CD40L interaction is also required for formation of B memory cells and germinal centers, and signaling through CD40 prevents apoptosis of germinal center B cells. Defective expression of CD40L in humans leads to an inability to produce isotypes other than IgM (hyper IgM syndrome), and to an absence of germinal centers. More recent evidence indicates an expansion of the role of the CD40-CD40L axis in cellular interactions beyond antibody formation. Induced expression of CD40 on monocytes can lead to CD40L-activated monocyte effector mechanisms. In addition, CD40-CD40L interactions are crucially involved in development of autoimmune disease in a number of animal models. CD40-CD40L interactions also impact on growth regulation of certain carcinomas. Manipulation of CD40L has also been used to develop novel strategies for long-term antigen-specific tolerization of peripheral T cells. Finally, the CD40-CD40L axis is involved in thymic selection. Following is a comprehensive overview of CD40L-CD40 interactions in physiological and pathogenic cellular responses and a discussion of the therapeutic ramifications of these interactions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29773027     DOI: 10.1615/CritRevImmunol.v37.i2-6.100

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  22 in total

Review 1.  Cytokines and costimulation in acute graft-versus-host disease.

Authors:  Geoffrey R Hill; Motoko Koyama
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

2.  Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.

Authors:  Glenda E Gray; Ying Huang; Nicole Grunenberg; Fatima Laher; Surita Roux; Erica Andersen-Nissen; Stephen C De Rosa; Britta Flach; April K Randhawa; Ryan Jensen; Edith M Swann; Linda-Gail Bekker; Craig Innes; Erica Lazarus; Lynn Morris; Nonhlanhla N Mkhize; Guido Ferrari; David C Montefiori; Xiaoying Shen; Sheetal Sawant; Nicole Yates; John Hural; Abby Isaacs; Sanjay Phogat; Carlos A DiazGranados; Carter Lee; Faruk Sinangil; Nelson L Michael; Merlin L Robb; James G Kublin; Peter B Gilbert; M Juliana McElrath; Georgia D Tomaras; Lawrence Corey
Journal:  Sci Transl Med       Date:  2019-09-18       Impact factor: 17.956

Review 3.  T cell costimulation, checkpoint inhibitors and anti-tumor therapy.

Authors:  Dipankar Nandi; Sanmoy Pathak; Taru Verma; Madhulika Singh; Avik Chattopadhyay; Samriddhi Thakur; Abinaya Raghavan; Abhijeet Gokhroo
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

4.  [CD40LG is a novel immune- and stroma-related prognostic biomarker in the tumor microenvironment of invasive breast cancer].

Authors:  L Guo; Y Ma; T Li; J Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

Review 5.  Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation.

Authors:  Lana E Kandalaft; Denarda Dangaj Laniti; George Coukos
Journal:  Nat Rev Cancer       Date:  2022-09-15       Impact factor: 69.800

6.  Discrete modeling for integration and analysis of large-scale signaling networks.

Authors:  Pierre Vignet; Jean Coquet; Sébastien Auber; Matéo Boudet; Anne Siegel; Nathalie Théret
Journal:  PLoS Comput Biol       Date:  2022-06-13       Impact factor: 4.779

Review 7.  Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.

Authors:  Ottavia M Delmonte; Anna Villa; Luigi D Notarangelo
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

8.  CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation.

Authors:  Chang Jiang; Stephen J Trudeau; Taek-Chin Cheong; Rui Guo; Mingxiang Teng; Liang Wei Wang; Zhonghao Wang; Chiara Pighi; Carole Gautier-Courteille; Yijie Ma; Sizun Jiang; Chong Wang; Bo Zhao; Luc Paillard; John G Doench; Roberto Chiarle; Benjamin E Gewurz
Journal:  Cell Rep       Date:  2019-07-30       Impact factor: 9.423

Review 9.  RhoA as a Key Regulator of Innate and Adaptive Immunity.

Authors:  Matthias Bros; Katharina Haas; Lorna Moll; Stephan Grabbe
Journal:  Cells       Date:  2019-07-17       Impact factor: 6.600

10.  Allergen-Induced C5a/C5aR1 Axis Activation in Pulmonary CD11b+ cDCs Promotes Pulmonary Tolerance through Downregulation of CD40.

Authors:  Konstantina Antoniou; Fanny Ender; Tillman Vollbrandt; Yves Laumonnier; Franziska Rathmann; Chandrashekhar Pasare; Harinder Singh; Jörg Köhl
Journal:  Cells       Date:  2020-01-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.